UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000020151
Receipt number R000023275
Scientific Title Effect of a plant-derived ingredient containing food on lipid metabolism.
Date of disclosure of the study information 2015/12/18
Last modified on 2019/01/31 16:19:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of a plant-derived ingredient
containing food on lipid metabolism.

Acronym

Efflcacy of a plant-derived ingredient
containing food for postprandial
lipid metabolism.

Scientific Title

Effect of a plant-derived ingredient
containing food on lipid metabolism.

Scientific Title:Acronym

Efflcacy of a plant-derived ingredient
containing food for postprandial
lipid metabolism.

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effect of single
ingestion of a plant-derived
ingredient containing a food on
postprandial lipid metabolism in
healthy adults.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

8 hours of postprandial fat oxidation measurement by human calorimeter.

Key secondary outcomes

8 hours of postprandial energy expenditure and respiratory quotient measurement by human calorimeter.


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Single ingestion of plant-derived ingredient containing food (test food code: A001)->washout->Single ingestion of plant-derived ingredient not containing food (control food code: P001).

Interventions/Control_2

Single ingestion of plant-derived ingredient not containing food (control food code: P001))->washout->Single ingestion of plant-derived ingredient containing food (test food code: A001).

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

24 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

Healthy males and females.

Key exclusion criteria

1. difficult to participate the study due to dysfunctions liver, or the other dysfunctions.
2. experienced a seizures based on circulatory-diseases before, or is under treatment.
3. arrhythmic.
4. who takes medication for glucose or fat metabolism, or hypertention.
5. who have experienced a seizures based on neural disease.
6. who was given surgery for a disease or an injury 2 months prior to the study.
7. who was given gastrectomy and/or bypass of part of the intestine.
8. who have allergic reaction for food.
9. Individual experienced unpleasant feeling during blood drawing.
10. claustrophobia.
11. insomnia.
12. chronic headache (migraine, tension headache, cluster headache, etc. ).
13. Person who donated more than 200mL of blood within a month, or more than 400mL within three months prior to informed consent.
14. who sleep habitually after 1:00 a.m. on weekday.
15. Heavy smoker
16. who had a weight change of more than +-2.0 kg for one month prior to informed consent.
17. who is engaged in night work and shift operations for more than 3 months prior to informed consent.
18. who is pregnant or expecting pregnancy.
19. who habitually take the foods for specified health uses (FOSHU) or functional food which solicits body fat reduction and absorption suppression of lipid or the carbohydrates (except for person who can stop consume them after informed consent.).
20. who can't accept doctor to check health condition, accessing the health examination result for the past two years, prior to the study.
21. who can't disclose age, the latest health examination result.
22. who can't reply to the questionnaire about living situation and condition.
23. who cannot indicate a menstruation situation.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Noriko Osaki

Organization

Kao Corporation

Division name

R&D-Development Research-Healthcare Food Research

Zip code


Address

2-1-3, Bunka, Sumida-ku, Tokyo, 1318501, JAPAN

TEL

03-5630-7224

Email

osaki.noriko@kao.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Toshitaka Sakuda

Organization

Kao Corporation

Division name

R&D-Development Research-Healthcare Food Research

Zip code


Address

2-1-3, Bunka, Sumida-ku, Tokyo, 1318501, JAPAN

TEL

03-5630-7456

Homepage URL


Email

sakuda.toshitaka@kao.co.jp


Sponsor or person

Institute

Kao Corporation

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

花王株式会社ヘルスケア食品研究所(東京都)


Other administrative information

Date of disclosure of the study information

2015 Year 12 Month 18 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 12 Month 01 Day

Date of IRB


Anticipated trial start date

2015 Year 12 Month 21 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 12 Month 10 Day

Last modified on

2019 Year 01 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023275